180 related articles for article (PubMed ID: 23966577)
1. The use of metformin and colorectal cancer incidence in patients with type II diabetes mellitus.
Smiechowski B; Azoulay L; Yin H; Pollak MN; Suissa S
Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1877-83. PubMed ID: 23966577
[TBL] [Abstract][Full Text] [Related]
2. Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis.
Bodmer M; Becker C; Meier C; Jick SS; Meier CR
Cancer Epidemiol Biomarkers Prev; 2012 Feb; 21(2):280-6. PubMed ID: 22178569
[TBL] [Abstract][Full Text] [Related]
3. Metformin and the incidence of prostate cancer in patients with type 2 diabetes.
Azoulay L; Dell'Aniello S; Gagnon B; Pollak M; Suissa S
Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):337-44. PubMed ID: 21148757
[TBL] [Abstract][Full Text] [Related]
4. Initial metformin or sulphonylurea exposure and cancer occurrence among patients with type 2 diabetes mellitus.
Qiu H; Rhoads GG; Berlin JA; Marcella SW; Demissie K
Diabetes Obes Metab; 2013 Apr; 15(4):349-57. PubMed ID: 23137378
[TBL] [Abstract][Full Text] [Related]
5. Metformin and the risk of head and neck cancer: a case-control analysis.
Becker C; Jick SS; Meier CR; Bodmer M
Diabetes Obes Metab; 2014 Nov; 16(11):1148-54. PubMed ID: 25041125
[TBL] [Abstract][Full Text] [Related]
6. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.
Tseng CH
Diabetes Metab Res Rev; 2015 Sep; 31(6):619-26. PubMed ID: 25820555
[TBL] [Abstract][Full Text] [Related]
7. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.
Kowall B; Stang A; Rathmann W; Kostev K
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313
[TBL] [Abstract][Full Text] [Related]
8. Metformin and endometrial cancer risk in Chinese women with type 2 diabetes mellitus in Taiwan.
Tseng CH
Gynecol Oncol; 2015 Jul; 138(1):147-53. PubMed ID: 25913129
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case-control study.
Azoulay L; Schneider-Lindner V; Dell'aniello S; Schiffrin A; Suissa S
Pharmacoepidemiol Drug Saf; 2010 Apr; 19(4):335-42. PubMed ID: 20052677
[TBL] [Abstract][Full Text] [Related]
10. Metformin for primary colorectal cancer prevention in patients with diabetes: a case-control study in a US population.
Sehdev A; Shih YC; Vekhter B; Bissonnette MB; Olopade OI; Polite BN
Cancer; 2015 Apr; 121(7):1071-8. PubMed ID: 25424411
[TBL] [Abstract][Full Text] [Related]
11. Metformin and the risk of endometrial cancer: a case-control analysis.
Becker C; Jick SS; Meier CR; Bodmer M
Gynecol Oncol; 2013 Jun; 129(3):565-9. PubMed ID: 23523618
[TBL] [Abstract][Full Text] [Related]
12. A Cohort Study of Metformin and Colorectal Cancer Risk among Patients with Diabetes Mellitus.
Bradley MC; Ferrara A; Achacoso N; Ehrlich SF; Quesenberry CP; Habel LA
Cancer Epidemiol Biomarkers Prev; 2018 May; 27(5):525-530. PubMed ID: 29716927
[No Abstract] [Full Text] [Related]
13. Association of antidiabetic medication and statins with breast cancer incidence in women with type 2 diabetes.
Hosio M; Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Puistola U; Läärä E; Jukkola A; Karihtala P
Breast Cancer Res Treat; 2019 Jun; 175(3):741-748. PubMed ID: 30895533
[TBL] [Abstract][Full Text] [Related]
14. Metformin use and survival after colorectal cancer: A population-based cohort study.
Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
Int J Cancer; 2016 Jan; 138(2):369-79. PubMed ID: 26331456
[TBL] [Abstract][Full Text] [Related]
15. The use of metformin in patients with prostate cancer and the risk of death.
Bensimon L; Yin H; Suissa S; Pollak MN; Azoulay L
Cancer Epidemiol Biomarkers Prev; 2014 Oct; 23(10):2111-8. PubMed ID: 25017246
[TBL] [Abstract][Full Text] [Related]
16. Metformin is associated with a lower risk of colorectal cancer in Taiwanese patients with type 2 diabetes: A retrospective cohort analysis.
Tseng CH
Diabetes Metab; 2017 Oct; 43(5):438-445. PubMed ID: 28438547
[TBL] [Abstract][Full Text] [Related]
17. Antidiabetic medication, statins and the risk of endometrioid endometrial cancer in patients with type 2 diabetes.
Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Läärä E; Puistola U; Hinkula M
Gynecol Oncol; 2017 Sep; 146(3):636-641. PubMed ID: 28645427
[TBL] [Abstract][Full Text] [Related]
18. The use of metformin and the incidence of lung cancer in patients with type 2 diabetes.
Smiechowski BB; Azoulay L; Yin H; Pollak MN; Suissa S
Diabetes Care; 2013 Jan; 36(1):124-9. PubMed ID: 22923670
[TBL] [Abstract][Full Text] [Related]
19. Incidence of and risk factors for severe hypoglycaemia in treated type 2 diabetes mellitus patients in the UK--a nested case-control analysis.
Bruderer SG; Bodmer M; Jick SS; Bader G; Schlienger RG; Meier CR
Diabetes Obes Metab; 2014 Sep; 16(9):801-11. PubMed ID: 24612200
[TBL] [Abstract][Full Text] [Related]
20. Metformin use is associated with a decreased incidence of colorectal adenomas in diabetic patients with previous colorectal cancer.
Lee JH; Jeon SM; Hong SP; Cheon JH; Kim TI; Kim WH
Dig Liver Dis; 2012 Dec; 44(12):1042-7. PubMed ID: 22789400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]